Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-15-032676

Director sold 996 shares at $9.09 ($9,052)

  • Director acquired 1,980 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nash Duane · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-04-01 Grant or award : show line 1 in the form +1,980 $9.51 $18,830 13,012 D
2015-04-02 Sale : show line 2 in the form −996 $9.09 $9,052 12,016 D
Open-market sales · 996 sh · avg $9.09 · $9,052
Loading xslF345X03/doc4.xml…